Skip to main content
MEDIPAL HOLDINGS CORPORATION logo

MEDIPAL HOLDINGS CORPORATION — Investor Relations & Filings

Ticker · 7459 ISIN · JP3268950007 LEI · 353800PJDODZEA4NP730 T Wholesale and retail trade
Open in API
Filings indexed 82 across all filing types
Latest filing 2026-02-06 Major Shareholding Noti…
Country JP Japan
Listing T 7459

About MEDIPAL HOLDINGS CORPORATION

https://www.medipal.co.jp/english/

MEDIPAL HOLDINGS CORPORATION is a holding company that manages group companies engaged in the wholesale and distribution of pharmaceuticals, medical supplies, cosmetics, and daily necessities. The company's core activity is the prescription pharmaceutical wholesale business, which involves procuring and distributing a wide range of healthcare products, including diagnostics. The business also extends to over-the-counter (OTC) pharmaceuticals, consumer health products, and animal health supplies, serving as a critical link in the healthcare supply chain.

Recent filings

Filing Released Lang Actions
変更報告書（短期大量譲渡）
Major Shareholding Notification Classification · 1% confidence The document is a 'Large Shareholding Report' (大量保有報告書) filed in Japan, specifically a 'Change Report' (変更報告書). This type of filing is required when a shareholder's stake in a publicly traded company changes significantly (in this case, a decrease of over 1% due to a tender offer). This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks changes in significant share ownership levels.
2026-02-06 Japanese
変更報告書
Major Shareholding Notification Classification · 1% confidence The document is a 'Large Shareholding Report' (大量保有報告書) filed with the Kanto Local Finance Bureau in Japan. It details a change in shareholding status (変更報告書) by Medipal Holdings Corporation regarding its stake in Medical Data Vision Co., Ltd. This type of regulatory filing, which discloses significant ownership thresholds and changes in shareholding, is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2025-12-24 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activities, including the number of shares acquired, the total cost, and the status of treasury shares held. This specific regulatory filing for share repurchases corresponds to the 'Transaction in Own Shares' (POS) category.
2025-12-12 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the specific dates, quantities, and prices of shares repurchased by Medipal Holdings Corporation during the month of October 2025. This falls directly under the category of 'Transaction in Own Shares' (POS).
2025-11-13 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references Article 24-5-2 of the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a semi-annual report. H1 2025
2025-11-13 Japanese
半期報告書－第117期(2025/04/01－2025/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Medipal Holdings Corporation in Japan. It follows the format of a Japanese statutory financial filing under the Financial Instruments and Exchange Act (Article 24-5, Paragraph 1). It contains comprehensive financial statements, management analysis (MDA), and business performance data for the interim period (April 1, 2025, to September 30, 2025). As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-11-13 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.